SVIL and osteosarcoma: Supervillin co-activates transcription with the androgen receptor [24–26], is up-regulated by estrogen [27], has been implicated in non-BRC1/2 breast cancer [28], and regulates the survival of U2OS bone osteosarcoma cells by regulating the deubiquitination and stability of p53 [14].